ARTICLE | Product Development
BEATing COVID-19 from home
FDA, biopharmas are using real-world data from online initiative BEAT19 to inform clinical trial design
June 19, 2020 1:46 AM UTC
As knowledge regarding the natural history of COVID-19 continues to evolve, biopharmas are looking to real-world data generated from the BEAT19 initiative to inform clinical trial design for COVID-19 therapies.
Behavior, Environment and Treatments for COVID-19 (BEAT19), run by AI company xCures Inc., aims to collect demographic and health data from 100,000 non-hospitalized individuals in the U.S. with the goal of distinguishing between early and late onset symptoms, measuring the severity and duration of each symptom, and identifying contrasting symptoms between COVID-positive and COVID-negative cases. ...